Product Design, Manufacturing & Innovation Resources
بيت » Phases of Clinical Trials

Phases of Clinical Trials

1960
Clinical trial setting with researchers discussing drug development processes in pharmacology.

(صورة توضيحية فقط)

Clinical trials for new drugs are conducted in a structured, multi-phase process. Phase I assesses safety and dosage in a small group of healthy volunteers. Phase II evaluates efficacy and side effects in a larger group of patients. Phase III confirms efficacy, monitors side effects, and compares it to standard treatments in a large patient population before regulatory submission. Each phase refines the risk benefit ratio of the treatment, and a trial can be stopped when that ratio becomes unfavorable.

The modern clinical trial system is a cornerstone of evidence-based medicine, designed to rigorously test the safety and efficacy of new therapeutic interventions before they are made widely available. The process begins after extensive preclinical research on animals and in vitro models suggests a compound is promising. Phase I trials are the first-in-human studies, typically involving 20-100 healthy volunteers. The primary goal is to determine the drug’s safety profile, including the safe dosage range and identifying acute side effects. Pharmacokinetics (how the body absorbs, distributes, metabolizes, and excretes the drug) is also a key focus. Phase II trials expand the study to several hundred patients who have the condition the drug is intended to treat. This phase aims to provide a preliminary assessment of the drug’s efficacy and to further evaluate its safety. Often, Phase II studies are randomized and include a placebo or standard treatment control group. Phase III التجارب السريرية هي دراسات محورية واسعة النطاق تشمل من عدة مئات إلى عدة آلاف من المرضى. وهي عادةً تجارب متعددة المراكز، عشوائية، مزدوجة التعمية، ومضبوطة، مصممة لتوفير الدليل القاطع على فعالية الدواء وسلامته اللازم للحصول على الموافقة التنظيمية. تُستخدم البيانات التي يتم جمعها في المرحلة الثالثة لمقارنة الدواء الجديد بالعلاجات الحالية أو دواء وهمي. في حال نجاحها، يمكن للجهة الراعية للدواء تقديم طلب للحصول على ترخيص دواء جديد.NDA) مع الهيئات التنظيمية مثل إدارة الغذاء والدواء الأمريكية. Phase IV, or post-marketing surveillance, occurs after the drug is approved and on the market. These studies monitor the drug’s long-term safety and effectiveness in a broad, diverse population, and can identify rare or long-term side effects not seen in the earlier, more controlled trials.

UNESCO Nomenclature: 3209
– Pharmacology

يكتب

Medical Procedure

خلل

أساسيات

الاستخدام

استخدام واسع النطاق

مقدمات

  • james lind’s 1747 scurvy trial, one of the first controlled clinical experiments
  • the nuremberg code (1947) establishing ethical principles for human experimentation
  • the declaration of helsinki (1964) providing ethical guidelines for medical research involving human subjects
  • the 1962 kefauver harris amendment to the fd&c act, requiring proof of efficacy

التطبيقات

  • development of all modern prescription drugs
  • approval process for اللقاحات
  • testing of new medical devices
  • post-market surveillance studies (phase iv)

براءات الاختراع:

NA

أفكار ابتكارية محتملة

  • adaptive clinical trial designs that modify parameters based on interim data
  • use of real-world evidence (rwe) from electronic health records to supplement trial data
  • decentralized clinical trials (dcts) using wearable tech and telemedicine
  • ai-powered patient recruitment and data analysis for faster trials
  • development of ‘digital twin’ patient models to simulate trial outcomes
  • platform trials testing multiple drugs for a single disease simultaneously
  • basket trials testing one drug on multiple diseases with a common biomarker
  • integration of genomic data for personalized trial enrollment
  • use of تقنية البلوك تشين for secure and transparent trial data management
  • development of novel endpoints using digital biomarkers from sensors
Related to: clinical trials, phase i, phase ii, phase iii, drug development, fda, efficacy, safety, pharmacology, new drug application.

السياق التاريخي

Phases of Clinical Trials

1960
1960
1969
1976-05-28
1980
1990
1960
1965
1970
1980
1980
1990

(إذا كان التاريخ غير معروف أو غير ذي صلة، على سبيل المثال "ميكانيكا الموائع"، يتم توفير تقدير تقريبي لظهوره الملحوظ)

أحدث الإضافات

أهم المنشورات والمقالات

أفضل الأدوات الأصلية

السنة العاشرة عيد

الصور والتنزيلات بالحجم الكامل متاحة فقط، ومجانية تمامًا، للأعضاء المسجلين.